ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 996,64
0,00%
Dow Jones
38 852,27
0,46%
DAX
18 175,21
1,01%
Brent Oil
83,36
-0,14%
Bitcoin
63 295,83
0,20%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. Heat Biologics Inc (HTBX)

  7. Heat Biologics Inc (HTBX) Actualités

HTBX

Heat Biologics (HTBX)

Heat Biologics Inc
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:HTBX
DateHeureSourceTitreSymboleSociété
15/05/202322h34Edgar (US Regulatory)Quarterly Report (10-q)AMEX:HTBXHeat Biologics Inc
15/05/202322h28Edgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
31/03/202322h15Edgar (US Regulatory)Annual Report (10-k)AMEX:HTBXHeat Biologics Inc
30/12/202222h06Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:HTBXHeat Biologics Inc
09/12/202223h04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:HTBXHeat Biologics Inc
06/06/202222h29Edgar (US Regulatory)Amended Current Report Filing (8-k/a)AMEX:HTBXHeat Biologics Inc
16/05/202222h44GlobeNewswire Inc.NightHawk Biosciences Provides First Quarter 2022 Business UpdateAMEX:HTBXHeat Biologics Inc
10/05/202214h00GlobeNewswire Inc.NightHawk Biosciences to Present at the 4th Annual Treg Directed Therapies Summit on PTX-35AMEX:HTBXHeat Biologics Inc
03/05/202213h00GlobeNewswire Inc.Heat Biologics Completes Name Change to NightHawk Biosciences; Trading to Commence Under “NHWK” Effective at the Market Open TodayAMEX:HTBXHeat Biologics Inc
27/04/202214h00GlobeNewswire Inc.Heat Biologics (NightHawk Biosciences) Announces that its Elusys Therapeutics Subsidiary has Executed a Contract to Deliver ANTHIM® to the Canadian GovernmentAMEX:HTBXHeat Biologics Inc
20/04/202214h00GlobeNewswire Inc.Heat Biologics (“NightHawk Biosciences”) Completes Acquisition of Elusys TherapeuticsAMEX:HTBXHeat Biologics Inc
19/04/202217h00GlobeNewswire Inc.Heat Biologics Announces Planned Name Change to NightHawk Biosciences, Reflecting Company’s Evolution, Therapeutic Pipeline Expansion, Vertical Integration and New Biodefense CapabilitiesAMEX:HTBXHeat Biologics Inc
18/04/202222h00GlobeNewswire Inc.REMINDER: Heat Biologics to Host Planned Investor and Media Livestream Event on Tuesday, April 19th at 10:30 AM ET to Discuss Latest DevelopmentsAMEX:HTBXHeat Biologics Inc
18/04/202214h30GlobeNewswire Inc.Heat Biologics’ Scorpion Subsidiary Announces Planned Development of New Kansas Commercial/Biodefense Biomanufacturing FacilityAMEX:HTBXHeat Biologics Inc
14/04/202218h35GlobeNewswire Inc.Heat Biologics’ Announces Planned Investor and Media Livestream Event to Discuss Latest DevelopmentsAMEX:HTBXHeat Biologics Inc
25/03/202213h00GlobeNewswire Inc.Heat Biologics Unveils Enhanced Allogeneic Cell Manufacturing ProcessAMEX:HTBXHeat Biologics Inc
11/03/202212h33Edgar (US Regulatory)Amended Securities Registration (section 12(b)) (8-a12b/a)AMEX:HTBXHeat Biologics Inc
 Showing the most relevant articles for your search:AMEX:HTBX

Dernières Valeurs Consultées

EU
ML
Michelin
SPI
SP500
S&P 500
NASDAQ
AAPL
Apple
EU
EN
Bouygues
EU
PX4
SBF 120
EU
LR
Legrand
EU
AI
Air Liquide
EU
VIV
Vivendi
EU
VK
Vallourec
USI
USTECH100
US Tech 100
EU
PX1
CAC 40
EU
MC
Lvmh Moet Hennessy Louis...
NASDAQ
MSFT
Microsoft
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés